Drug Information
| General Information | ||||||
|---|---|---|---|---|---|---|
| Drug ID |
DR00950
|
|||||
| Drug Name |
Phlorizin
|
|||||
| Synonyms |
1-Propanone, 1-(2-(b; 1-[2-(beta-D-Glucopyranosyloxy)-4,6-dihydroxyphenyl]-3-(4-hydroxyphenyl)-1-propanone; 2'-(beta-D-Glucopyranosyloxy)-4',6'-dihydroxy-3-(4-hydroxyphenyl)propiophenone; 60-81-1; AI3-19835; CHEBI:8113; CHEMBL245067; CU9S17279X; EINECS 200-487-1; Floridzin; IOUVKUPGCMBWBT-QNDFHXLGSA-N; NSC 2833; Phloretin 2'-glucoside; Phloretin-2'-O-beta-glucoside; Phloretin-2'-beta-glucoside; Phlorhizin; Phloridzin; Phloridzin dihydrate; Phloridzosid; Phlorizin; Phlorizine; Phlorizoside; Phlorrhizen; Phlorrhizin; UNII-CU9S17279X
|
|||||
| Drug Type |
Small molecular drug
|
|||||
| Indication | Discovery agent [ICD11: N.A.] | Investigative | ||||
| Structure |
|
 |
||||
| 3D MOL | 2D MOL | |||||
| Formula |
C21H24O10
|
|||||
| Canonical SMILES |
C1=CC(=CC=C1CCC(=O)C2=C(C=C(C=C2OC3C(C(C(C(O3)CO)O)O)O)O)O)O
|
|||||
| InChI |
InChI=1S/C21H24O10/c22-9-16-18(27)19(28)20(29)21(31-16)30-15-8-12(24)7-14(26)17(15)13(25)6-3-10-1-4-11(23)5-2-10/h1-2,4-5,7-8,16,18-24,26-29H,3,6,9H2/t16-,18-,19+,20-,21-/m1/s1
|
|||||
| InChIKey |
IOUVKUPGCMBWBT-QNDFHXLGSA-N
|
|||||
| CAS Number |
CAS 60-81-1
|
|||||
| Pharmaceutical Properties | Molecular Weight | 436.4 | Topological Polar Surface Area | 177 | ||
| Heavy Atom Count | 31 | Rotatable Bond Count | 7 | |||
| Hydrogen Bond Donor Count | 7 | Hydrogen Bond Acceptor Count | 10 | |||
| XLogP |
1.2
|
|||||
| PubChem CID | ||||||
| ChEBI ID |
CHEBI:8113
|
|||||
| TTD Drug ID | ||||||
| DT(s) Transporting This Drug | MRP2 | Transporter Info | Multidrug resistance-associated protein 2 | Substrate | [1] | |
| References | ||||||
| 1 | Mammalian drug efflux transporters of the ATP binding cassette (ABC) family in multidrug resistance: A review of the past decade. Cancer Lett. 2016 Jan 1;370(1):153-64. | |||||
If you find any error in data or bug in web service, please kindly report it to Dr. Yin and Dr. Li.